Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,248
datasets available to search
ShareScore release 0.9.0
Dataset results
2,248 results for “squamous cell carcinoma”
Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.
ClinicalTrials.gov study NCT04750824. IPD Sharing: NO. Countries: 1. Publications: 0.
IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00229723. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line
ClinicalTrials.gov study NCT03288298. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (
ClinicalTrials.gov study NCT03709706. IPD Sharing: YES. Countries: 5. Publications: 0.
Study of RADPLAT and Tarceva in Locally Advanced Head and Neck Squamous Cell Carcinoma (SCCA)
ClinicalTrials.gov study NCT00304278. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
ClinicalTrials.gov study NCT00054691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
ClinicalTrials.gov study NCT01823679. IPD Sharing: NO. Countries: 1. Publications: 0.
Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck
ClinicalTrials.gov study NCT04397341. IPD Sharing: NO. Countries: 0. Publications: 1.
Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma
ClinicalTrials.gov study NCT01764607. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07374003. IPD Sharing: YES. Countries: 1. Publications: 0.
RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY
ClinicalTrials.gov study NCT05570487. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
ClinicalTrials.gov study NCT01927744. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck
ClinicalTrials.gov study NCT00617734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
ClinicalTrials.gov study NCT03655444. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07379424. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
ClinicalTrials.gov study NCT05323656. IPD Sharing: UNDECIDED. Countries: 7. Publications: 0.
Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%
ClinicalTrials.gov study NCT01926496. IPD Sharing: NO. Countries: 3. Publications: 0.
Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04922450. IPD Sharing: YES. Countries: 1. Publications: 0.
Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck
ClinicalTrials.gov study NCT00459043. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06485778. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.